Global RNA Sequencing Market

         2.1    Scope of Work
         2.2    Key Questions Answered in the Report

 
         3.1    Global RNA Sequencing Market: Research Methodology
         3.2    Data Sources
         3.3    Secondary Data Sources
         3.4    Market Estimation Model
         3.5    Criteria for Company Profiling

         4.1    Current State of RNA Sequencing
         4.2    Market Footprint and Future Potential
                  4.2.1    North America
                              4.2.1.1    Future Potential
                  4.2.2    Europe
                              4.2.2.1    Future Potential
                  4.2.3    Asia-Pacific
                              4.2.3.1    Future Potential
                  4.2.4    Latin America
                              4.2.4.1    Future Potential
                  4.2.5    Rest-of-the-World
                              4.2.5.1    Future Potential
         4.3    Technology Assessment
         4.4    Commercialized Platforms and Applications

         5.1    Legal and Regulatory Framework
                  5.1.1    U.S.
                              5.1.1.1    Guidelines Published in FY2018
                              5.1.1.2    Guidelines Published in FY2016
                  5.1.2    Europe
                  5.1.3    Japan
         5.2    Patent Landscape
         5.3    Comparison of RNA Sequencing Costs
         5.4    Publication Statistics

         6.1    Overview
         6.2    Impact Analysis of Market Dynamics
         6.3    Market Drivers
                  6.3.1    Increase in Adoption of Personalized Medicine due to Decrease in Cost of Sequencing
                  6.3.2    Increased Utility in Predictive Biomarkers and Therapeutic Response Research
                  6.3.3    Significant External Funding for Executing Research and Development
         6.4    Market Restraints
                  6.4.1    Expected Implementation of Patient Protection and Affordable Care Act in the U.S
                  6.4.2    Existing Lawsuits
                  6.4.3    High Capital Requirement Hampering the Expansion of Global Reach
         6.5    Market Opportunities
                  6.5.1    Development of Portable and Cost-Efficient Technologies
                  6.5.2    Hybridization of Technologies

         7.1    Key Strategies and Developments
                  7.1.1    Product Launch and Upgradations
                  7.1.2    Synergistic Activities
                  7.1.3    Funding and Expansions
                  7.1.4    Mergers and Acquisitions
                  7.1.5    Product Approvals
         7.2    Market Share Analysis
         7.3    Growth Share Analysis (by Companies), 2018

         8.1    Overview
         8.2    Instruments
                  8.2.1    Fully Automated Systems
                  8.2.2    Semi-Automated Instruments
         8.3    Reagents and Kits
                  8.3.1    Sample Enrichment
                  8.3.2    Sample Isolation and Extraction
                  8.3.3    Library Preparation
                  8.3.4    Sequencing
         8.4    Software

         9.1    Overview
         9.2    Single Molecule Based Sequencing
         9.3    Sequence by Synthesis Technology
         9.4    Nanopore Sequencing Technology
         9.5    Ion Torrent Semiconductor Sequencing

           10.1    Overview
           10.2    Sample Isolation and Extraction
                      10.2.1    Market Size and Future Potential
           10.3    Sample Enrichment
                      10.3.1    Market Size and Future Potential
           10.4    Library Preparation
                      10.4.1    Market Size and Future Potential
           10.5    Sequencing
                      10.5.1    Market Size and Future Potential
           10.6    Data Analysis and Management
                      10.6.1    Market Size and Future Potential

           11.1    Overview
           11.2    Biopharmaceuticals
           11.3    Diagnostic Centers
           11.4    Life-sciences and Biotechnology Companies
           11.5    Research and Academia

           12.1    Overview
           12.2    Diagnostics
                      12.2.1    Market Size and Future Potential
           12.3    Drug Discovery
                      12.3.1    Market Size and Future Potential
           12.4    Translational Medicine
                      12.4.1    Market Size and Future Potential
           12.5    Others

           13.1    Overview
           13.2    North America
                      13.2.1    Key Dynamics
                      13.2.2    Competitive Landscape
                      13.2.3    U.S.
                                    13.2.3.1    Market Size and Growth Potential
                                    13.2.3.2    New Market Opportunities
                                    13.2.3.3    Unmet Needs
                      13.2.4    Canada
                                    13.2.4.1    Market Size and Growth Potential
                                    13.2.4.2    New Market Opportunities
                                    13.2.4.3    Unmet Needs
           13.3    Europe
                      13.3.1    Key Dynamics
                      13.3.2    Competitive Landscape
                      13.3.3    Germany
                                    13.3.3.1    Market Size and Growth Potential
                                    13.3.3.2    New Market Opportunities
                                    13.3.3.3    Unmet Needs
                      13.3.4    U.K.
                                    13.3.4.1    Market Size and Growth Potential
                                    13.3.4.2    New Market Opportunities
                                    13.3.4.3    Unmet Needs
                      13.3.5    France
                                    13.3.5.1    Market Size and Growth Potential
                                    13.3.5.2    New Market Opportunities
                                    13.3.5.3    Unmet Needs
                      13.3.6    Italy
                                    13.3.6.1    Market Size and Growth Potential
                                    13.3.6.2    New Market Opportunities
                                    13.3.6.3    Unmet Needs
                      13.3.7    Spain
                                    13.3.7.1    Market Size and Growth Potential
                                    13.3.7.2    New Market Opportunities
                                    13.3.7.3    Unmet Needs
                      13.3.8    Russia
                                    13.3.8.1    Market Size and Growth Potential
                      13.3.9    Rest-of-Europe
           13.4    Asia-Pacific
                      13.4.1    Key Dynamics
                      13.4.2    Competitive Landscape
                      13.4.3    China
                                    13.4.3.1    Market Size and Growth Potential
                                    13.4.3.2    New Market Opportunities
                                    13.4.3.3    Unmet Needs
                      13.4.4    Japan
                                    13.4.4.1    Market Size and Growth Potential
                                    13.4.4.2    New Market Opportunities
                                    13.4.4.3    Unmet Needs
                      13.4.5    India
                                    13.4.5.1    Market Size and Growth Potential
                                    13.4.5.2    New Market Opportunities
                                    13.4.5.3    Unmet Needs
                      13.4.6    Australia
                                    13.4.6.1    Market Size and Growth Potential
                                    13.4.6.2    New Market Opportunities
                                    13.4.6.3    Unmet Needs
                      13.4.7    South Korea
                                    13.4.7.1    Market Size and Growth Potential
                                    13.4.7.2    New Market Opportunities
                                    13.4.7.3    Unmet Needs
                      13.4.8    Rest-of-APAC
           13.5    Latin America
                      13.5.1    Key Dynamics
                      13.5.2    Brazil
                                    13.5.2.1    Market Size and Growth Potential
                                    13.5.2.2    New Market Opportunities
                                    13.5.2.3    Unmet Needs
                      13.5.3    Mexico
                                    13.5.3.1    Market Size and Growth Potential
                                    13.5.3.2    New Market Opportunities
                                    13.5.3.3    Unmet Needs
                      13.5.4    Rest-of-Latin America
           13.6    Rest-of-the-World
                      13.6.1    Key Dynamics
                                    13.6.1.1    New Market Opportunities
                                    13.6.1.2    Unmet Needs

           14.1    Overview
           14.2    Agilent Technologies, Inc.
                      14.2.1    Company Overview
                      14.2.2    Role of Agilent Technologies, Inc. in the Global RNA Sequencing Market
                      14.2.3    Financials
                      14.2.4    Key Insights About Financial Health of the Company
                      14.2.5    SWOT Analysis
           14.3    Bio-Rad Laboratories, Inc.
                      14.3.1    Company Overview
                      14.3.2    Role of Bio-Rad Laboratories, Inc. in the Global RNA Sequencing Market
                      14.3.3    Financials
                      14.3.4    Key Insights About Financial Health of the Company
                      14.3.5    SWOT Analysis
           14.4    BGI
                      14.4.1    Company Overview
                      14.4.2    Role of BGI in the Global RNA Sequencing Market
                      14.4.3    Financials
                      14.4.4    Key Insights About Financial Health of the Company
                      14.4.5    SWOT Analysis
           14.5    F. Hoffmann-La Roche AG
                      14.5.1    Company Overview
                      14.5.2    Role of F. Hoffmann-La Roche AG in the Global RNA Sequencing Market
                      14.5.3    Financials
                      14.5.4    Key Insights About Financial Health of the Company
                      14.5.5    SWOT Analysis
           14.6    Fluidigm Corporation
                      14.6.1    Company Overview
                      14.6.2    Role of Fluidigm Corporation in the Global RNA Sequencing Market
                      14.6.3    Financials
                      14.6.4    Key Insights About Financial Health of the Company
                      14.6.5    SWOT Analysis
           14.7    Illumina, Inc.
                      14.7.1    Company Overview
                      14.7.2    Role of Illumina, Inc. in the Global RNA Sequencing Market
                      14.7.3    Financials
                      14.7.4    Key Insights About Financial Health of the Company
                      14.7.5    SWOT Analysis
           14.8    Lexogen GmbH
                      14.8.1    Company Overview
                      14.8.2    Role of Lexogen GmbH in the Global RNA Sequencing Market
                      14.8.3    SWOT Analysis
           14.9    Oxford Nanopore Technologies
                      14.9.1    Company Overview
                      14.9.2    Role of Oxford Nanopore Technologies in the Global RNA Sequencing Market
                      14.9.3    SWOT Analysis
          14.10   Pacific Biosciences
                      14.10.1    Company Overview
                      14.10.2    Role of Pacific Biosciences in the Global RNA Sequencing Market
                      14.10.3    Financials
                      14.10.4    Key Insights About Financial Health of the Company
                      14.10.5    SWOT Analysis
           14.11   Dolomite Bio
                      14.11.1    Company Overview
                      14.11.2    Role of Dolomite Bio. in the Global RNA Sequencing Market
                      14.11.3    SWOT Analysis
          14.12   Merck KGaA
                      14.12.1    Company Overview
                      14.12.2    Role of Merck KGaA in the Global RNA Sequencing Market
                      14.12.3    Financials
                      14.12.4    Key Insights About Financial Health of the Company
                      14.12.5    SWOT Analysis
          14.13   Becton, Dickinson and Company
                      14.13.1    Company Overview
                      14.13.2    Role of Becton, Dickinson and Company in the Global RNA Sequencing Market
                      14.13.3    Financials
                      14.13.4    Key Insights About Financial Health of the Company
                      14.13.5    SWOT Analysis
          14.14   Takara Bio Inc.
                      14.14.1    Company Overview
                      14.14.2    Role of Takara Bio Inc. in the Global RNA Sequencing Market
                      14.14.3    Financials
                      14.14.4    Key Insights About Financial Health of the Company
                      14.14.5    SWOT Analysis
          14.15   QIAGEN N.V.
                      14.15.1    Company Overview
                      14.15.2    Role of QIAGEN N.V. plc in the Global RNA Sequencing Market
                      14.15.3    Financials
                      14.15.4    Key Insights About Financial Health of the Company
                      14.15.5    SWOT Analysis
          14.16   Thermo Fisher Scientific Inc.
                      14.16.1    Company Overview
                      14.16.2    Role of Thermo Fisher Scientific in the Global RNA Sequencing Market
                      14.16.3    Financials
                      14.16.4    Key Insights About Financial Health of the Company
                      14.16.5    SWOT Analysis

Table 4.1:    Assessment of Existing Technologies in Global RNA Sequencing Market
Table 4.2:    Key Commercialized Products Offered by Major Market Players
Table 5.1:    Performance and Cost Comparison of Sequencing Platforms of Various Generations
Table 6.1:    Cost comparison Analysis of Portable Sequencers
Table 8.1:    Specifications of Available Instruments in the Market
Table 8.2:    Respective Offerings of Key Players in Kits Segment
Table 8.3:    Key Products (Kits and Reagents) Currently Offered by Key Market Players

Figure 1:    Implications of RNA Sequencing
Figure 2:    Cumulative Number of Genes Linked to Rare Diseases, 2010-2018
Figure 3:    Impact Analysis of Market Drivers and Market Challenges on the Global RNA Sequencing Market
Figure 4:    Global RNA Sequencing Market, by Product Type, 2018 vs. 2028 ($Million)
Figure 5:    Global RNA Sequencing Market, by Technology, 2018 vs. 2028 ($Million)
Figure 6:    Global RNA Sequencing Market, by Workflow, 2018 vs. 2028 ($Million)
Figure 7:    Global RNA Sequencing Market, by End User, 2018 vs. 2028 ($Million)
Figure 8:    Global RNA Sequencing Market, by Application, 2018 vs. 2028 ($Million)
Figure 9:    Global RNA Sequencing Market Snapshot
Figure 2.1:    Global RNA Sequencing Market Segmentation
Figure 3.1:    Global RNA Sequencing Market Research Methodology
Figure 3.2:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.3:    Top-Down Approach (Segment-Wise Analysis)
Figure 4.1:    North America RNA Sequencing Market, 2018-2028
Figure 4.2:    North America RNA Sequencing Market – Key Driving Factors & Impact
Figure 4.3:    Europe RNA Sequencing Market, 2018-2028
Figure 4.4:    Europe RNA Sequencing Market – Key Driving Factors & Impact
Figure 4.5:    Asia-Pacific RNA Sequencing Market, 2018-2028
Figure 4.6:    Asia-Pacific RNA Sequencing Market – Key Driving Factors & Impact
Figure 4.7:    Latin America RNA Sequencing Market, 2018-2028
Figure 4.8:    Latin America RNA Sequencing Market – Key Driving Factors & Impact
Figure 4.9:    Rest-of-the-World RNA Sequencing Market, 2018-2028
Figure 4.10:    Rest-of-the-World RNA Sequencing Market – Key Driving Factors & Impact
Figure 5.1:    Global RNA Sequencing Market: Existing Patent Segmentation
Figure 5.2:    NGS RNA Sequencing Publications (2009-2017)
Figure 6.1:    Impact Analysis of Market Drivers and Restraints
Figure 6.2:    Cost of Genome Sequencing 2010-2018
Figure 6.3:    Global RNA Sequencing Market: Funding Scenario (FY2016-FY2019)
Figure 7.1:    Key Developments and Strategies, 2016–2019
Figure 7.2:    Product Launch and Upgradations (by Company), 2016–2019
Figure 7.3:    Synergistic Activities (by Company), 2016 –2019
Figure 7.4:    Funding and Expansions (by Company), 2016 –2019
Figure 7.5:    Mergers and Acquisitions Share (by Company), 2016 –2019
Figure 7.6:    Product Approvals Share (by Company), 2016 –2019
Figure 7.7:    Market Share Analysis for the Global RNA Sequencing Market, 2018
Figure 7.8:    Growth Share Matrix for Global RNA Sequencing Market (by Companies), 2018
Figure 8.1:    Global RNA Sequencing Market (by Product Type)
Figure 8.2:    Global RNA Sequencing Market (by Product Type), 2019 and 2028
Figure 8.3:    Global RNA Sequencing Market for Instruments, 2018-2028
Figure 8.4:    Global RNA Sequencing Market for Fully Automated Instruments, 2018-2028
Figure 8.5:    Global RNA Sequencing Market for Semi-Automated Instruments, 2018-2028
Figure 8.6:    Global RNA Sequencing Market for Reagents and Kits, 2018-2028
Figure 8.7:    Global Sample Enrichment Reagent and Kits Market, 2018-2028
Figure 8.8:    Global Sample Isolation, Extraction Reagent and Kits Market, 2018-2028
Figure 8.9:    Global Library Preparation Reagent and Kits Market, 2018-2028
Figure 8.10:    Global Sequencing Reagent and Kits Market, 2018-2028
Figure 8.11:    Global RNA Sequencing Market for Software, 2018-2028
Figure 9.1:    Global RNA Sequencing Market (by Technology), 2018-2028
Figure 9.2:    Global RNA Sequencing Market for Single Molecule Based Sequencing Technology Segment, 2018-2028
Figure 9.3:    Global RNA Sequencing Market for Sequence by Synthesis Technology Segment, 2018-2028
Figure 9.4:    Global RNA Sequencing Market for Nanopore Sequencing Technology Segment, 2018-2028
Figure 9.5:    Global RNA Sequencing Market for Ion Torrent Semiconductor Sequencing Technology Segment, 2018-2028
Figure 10.1:    Global RNA Sequencing Market (by Workflow), 2019 and 2028
Figure 10.2:    Global RNA Sequencing Market for Sample Isolation and Extraction, 2018-2028
Figure 10.3:    Global RNA Sequencing Market for Sample Enrichment, 2018-2028
Figure 10.4:    Global RNA Sequencing Market for Library Preparation, 2018-2028
Figure 10.5:    Global RNA Sequencing Market for Sequencing, 2018-2028
Figure 10.6:    Global RNA Sequencing Market for Data Analysis and Management, 2018-2028
Figure 11.1:    Global RNA Sequencing Market (by End User)
Figure 11.2:    Global RNA Sequencing Market (by End User), 2019 and 2028
Figure 11.3:    Global RNA Sequencing Market for Biopharmaceuticals, 2018-2028
Figure 11.4:    Global RNA Sequencing Market for Diagnostic Centers, 2018-2028
Figure 11.5:    Global RNA Sequencing Market for Life-Sciences and Biotechnology Companies, 2018-2028
Figure 11.6:    Global RNA Sequencing Market for Research and Academia, 2018-2028
Figure 12.1:    Global RNA Sequencing Market (by Application), 2019 and 2028
Figure 12.2:    Global RNA Sequencing Market for Diagnostics, 2018-2028
Figure 12.3:    Global RNA Sequencing Market for Drug Discovery, 2018-2028
Figure 12.4:    Global RNA Sequencing Market for Translational Medicine, 2018-2028
Figure 12.5:    Global RNA Sequencing Market for Other Applications Market, 2018-2028
Figure 13.1:    RNA Sequencing Market (by Region), 2019 and 2028
Figure 13.2:    RNA Sequencing Market (by Region), 2018-2028
Figure 13.3:    North America: Market Dynamics
Figure 13.4:    North America RNA Sequencing Market, (by Country), 2018-2028
Figure 13.5:    North America: Growth Strategies by Key Market Players, (2016-2019)
Figure 13.6:    North America: Competitive Assessment of Key Market Players
Figure 13.7:    U.S. RNA Sequencing Market), 2018-2028
Figure 13.8:    Canada RNA Sequencing Market, 2018-2028
Figure 13.9:    Europe: Market Dynamics
Figure 13.10:    Europe RNA Sequencing Market, (by Country), 2018-2028
Figure 13.11:    Europe: Growth Strategies by Key Market Players, (2016-2019)
Figure 13.12:    Europe: Competitive Assessment of Key Market Players
Figure 13.13:    Germany RNA Sequencing Market, 2018-2028
Figure 13.14:    U.K. RNA Sequencing Market, 2018-2028
Figure 13.15:    France RNA Sequencing Market, 2018-2028
Figure 13.16:    Italy RNA Sequencing Market, 2018-2028
Figure 13.17:    Spain RNA Sequencing Market, 2018-2028
Figure 13.18:    Russia RNA Sequencing Market, 2018-2028
Figure 13.19:    Rest-of-Europe RNA Sequencing Market, 2018-2028
Figure 13.20:    Asia-Pacific: Market Dynamics
Figure 13.21:    Asia-Pacific RNA Sequencing Market, (by Country), 2018-2028
Figure 13.22:    Asia-Pacific: Growth Strategies by Key Market Players, (2016-2019)
Figure 13.23:    Asia-Pacific: Competitive Assessment of Key Market Players
Figure 13.24:    China RNA Sequencing Market, 2018-2028
Figure 13.25:    Japan RNA Sequencing Market, 2018-2028
Figure 13.26:    India RNA Sequencing Market, 2018-2028
Figure 13.27:    Australia RNA Sequencing Market, 2018-2028
Figure 13.28:    South Korea RNA Sequencing Market, 2018-2028
Figure 13.29:    Rest-of-APAC RNA Sequencing Market, 2018-2028
Figure 13.30:    Latin America: Market Dynamics
Figure 13.31:    Latin America RNA Sequencing Market, (by Country), 2018-2028
Figure 13.32:    Brazil RNA Sequencing Market, 2018-2028
Figure 13.33:    Mexico RNA Sequencing Market, 2018-2028
Figure 13.34:    Rest-of-Latin America RNA Sequencing Market, 2018-2028
Figure 13.35:    Rest-of-the-World: Market Dynamics
Figure 13.36:    Rest-of-the-World RNA Sequencing Market, 2018-2028
Figure 14.1:    Total Number of Companies Profiled
Figure 14.2:    Agilent Technologies, Inc.: Overall Product Portfolio
Figure 14.3:    Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 14.4:    Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
Figure 14.5:    Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 14.6:    Agilent Technologies, Inc.: R&D Expenditure, 2017-2019
Figure 14.7:    Agilent Technologies, Inc.: SWOT Analysis
Figure 14.8:    Bio-Rad Laboratories, Inc.: Overall Product Portfolio
Figure 14.9:    Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 14.10:    Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2016-2018
Figure 14.11:    Bio-Rad Laboratories, Inc.: Sales (by Region), 2016-2018
Figure 14.12:    Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
Figure 14.13:    Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 14.14:    BGI: Overall Product Portfolio
Figure 14.15:    BGI: Overall Financials, 2017-2018
Figure 14.16:    BGI: Sales (by Segment), 2017-2018
Figure 14.17:    BGI: Sales (by Region), 2017-2018
Figure 14.18:    BGI: R&D Expenditure, 2017-2018
Figure 14.19:    BGI: SWOT Analysis
Figure 14.20:    F. Hoffmann-La Roche AG: Overall Product Portfolio
Figure 14.21:    F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
Figure 14.22:    F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2016-2018
Figure 14.23:    F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
Figure 14.24:    F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
Figure 14.25:    F. Hoffmann-La Roche AG: SWOT Analysis
Figure 14.26:    Fluidigm Corporation: Overall Product Portfolio
Figure 14.27:    Fluidigm Corporation: Overall Financials, 2016-2018
Figure 14.28:    Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
Figure 14.29:    Fluidigm Corporation: Revenue (by Region), 2016-2018
Figure 14.30:    Fluidigm Corporation: R&D Expenditure, 2016-2018
Figure 14.31:    Fluidigm Corporation: SWOT Analysis
Figure 14.32:    Illumina, Inc.: Overall Product Portfolio
Figure 14.33:    Illumina, Inc.: Overall Financials, 2016-2018
Figure 14.34:    Illumina, Inc.: Revenue (by Segment), $Million, 2016-2018
Figure 14.35:    Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 14.36:    Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 14.37:    Illumina, Inc.: SWOT Analysis
Figure 14.38:    Lexogen GmbH: Overall Product Portfolio
Figure 14.39:    Lexogen GmbH: SWOT Analysis
Figure 14.40:    Oxford Nanopore Technologies: Product Offerings
Figure 14.41:    Oxford Nanopore Technologies: SWOT Analysis
Figure 14.42:    Pacific Biosciences: Existing Product Offerings in Global RNA Sequencing Market
Figure 14.43:    Pacific Biosciences: Overall Financials, 2016-2018
Figure 14.44:    Pacific Biosciences: Revenue (by Region), 2016-2018
Figure 14.45:    Pacific Biosciences: R&D Expenditure, 2016-2018
Figure 14.46:    Pacific Biosciences: SWOT Analysis
Figure 14.47:    Dolomite Bio.: Existing Product Offerings in Global RNA Sequencing Market
Figure 14.48:    Dolomite Bio.: SWOT Analysis
Figure 14.49:    Merck KGaA: Existing Product Offerings in the Global RNA Sequencing Market
Figure 14.50:    Merck KGaA: Overall Financials, 2016-2018
Figure 14.51:    Merck KGaA: Revenue (by Segment), $Million, 2016-2018
Figure 14.52:    Merck KGaA: Revenue (by Region), 2016-2018
Figure 14.53:    Merck KGaA: R&D Expenditure, 2016-2018
Figure 14.54:    Merck KGaA: SWOT Analysis
Figure 14.55:    Beckton, Dickinson and Company: Existing Product Offerings in Global RNA Sequencing Market
Figure 14.56:    Becton, Dickinson and Company: Overall Financials, 2017-2019
Figure 14.57:    Becton, Dickinson and Company: Revenue (by Business Segment), 2017-2019
Figure 14.58:    Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2017-2019
Figure 14.59:    Becton, Dickinson and Company: Revenue (by Region), 2017-2019
Figure 14.60:    Becton, Dickinson and Company: R&D Expenditure, 2017-2019
Figure 14.61:    Becton, Dickinson and Company: SWOT Analysis
Figure 14.62:    Takara Bio Inc.: Existing Product Offerings in Global RNA  Sequencing Market
Figure 14.63:    Takara Bio Inc.: Overall Financials, 2017-2019
Figure 14.64:    Takara Bio Inc.: Revenue (by Segment), 2017-2019
Figure 14.65:    Takara Bio Inc.: Revenue (by Region), 2017-2019
Figure 14.66:    Takara Bio Inc.: R&D Expenditure, 2017-2019
Figure 14.67:    Takara Bio Inc.: SWOT Analysis
Figure 14.68:    QIAGEN N.V.: Existing Product Offerings in Global RNA Sequencing Market
Figure 14.69:    QIAGEN N.V.: Overall Financials, 2016-2018
Figure 14.70:    QIAGEN N.V.: Revenue (by Segment), $Million, 2016-2018
Figure 14.71:    QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 14.72:    QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 14.73:    QIAGEN N.V.: SWOT Analysis
Figure 14.74:    Thermo Fisher Scientific Inc.: Existing Product Offerings in Global RNA Sequencing Market
Figure 14.75:    Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 14.76:    Thermo Fisher Scientific Inc: Sales (by Segment), $Billion, 2016-2018
Figure 14.77:    Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
Figure 14.78:    Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 14.79:    Thermo Fisher Scientific Inc.: SWOT Analysis